How can I differentiate hypopigmented macules that may represent ash‑leaf spots of tuberous sclerosis from early vitiligo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differentiating Ash-Leaf Spots from Early Vitiligo

Use dermoscopy to distinguish ash-leaf macules of tuberous sclerosis from early vitiligo: ash-leaf spots show characteristic sharply demarcated areas of normal pigment network within the depigmented lesion, while vitiligo shows complete absence of pigment network with perifollicular pigment retention. 1, 2

Key Dermoscopic Features

Ash-Leaf Macules (Tuberous Sclerosis)

  • Pathognomonic finding: Sharply demarcated "islands" or patches of normal pigment network within the depigmented area (seen in 88.2% of cases) 1
  • Hypopigmented rather than completely depigmented
  • Faint pigment network visible throughout the lesion 1
  • Well-defined borders
  • Lower sensitivity on dermoscopy (46.7-52.6%) compared to vitiligo 2

Early Vitiligo

  • Complete absence of pigment network (66.7% of cases) 1
  • Intermediate or ill-defined margins (91.4% of cases) 3, 1
  • Perifollicular pigment retention (statistically significant differentiator, P <0.001) 1
  • Perilesional hyperpigmentation 1
  • Loss of discernible eccrine openings within the lesion 1
  • No scaling present 1
  • Dermoscopy sensitivity of 94.7% 2

Clinical Context Matters

Distribution Patterns

Vitiligo typically affects:

  • Fingers and wrists
  • Axillae and groins
  • Body orifices (mouth, eyes, genitalia)
  • Often symmetrical distribution 3

Ash-leaf macules can appear:

  • Anywhere on the body
  • Present from birth or early infancy
  • Non-progressive 4

Associated Features

For vitiligo, look for:

  • Progressive enlargement over time 3
  • Possible "trichrome" appearance (white center with intermediate pale area) 3
  • White hair within patches (leukotrichia)
  • Family history of autoimmune disease (32% of patients) 3
  • No surface changes, usually no redness 3

For tuberous sclerosis, screen for:

  • Multiple hypopigmented macules (≥3 suggests TSC)
  • Other TSC features: facial angiofibromas, shagreen patches, cardiac rhabdomyomas
  • Seizures or developmental delays
  • Positive family history 5, 6

Diagnostic Algorithm

  1. Perform dermoscopy first - This is the most efficient differentiator

    • Presence of sharply demarcated pigment network islands → ash-leaf macule
    • Complete pigment network absence with perifollicular retention → vitiligo
  2. Use Wood's lamp examination - Enhances visualization in fair skin (skin types I-II) 3

    • Both conditions will show enhanced contrast under UV light
    • Helps delineate extent but doesn't differentiate between conditions
  3. Assess clinical context:

    • Age of onset: Congenital/early infancy favors ash-leaf macule
    • Progression: Enlarging lesions favor vitiligo
    • Distribution: Acral/perioral favors vitiligo
  4. If ash-leaf macules suspected: Evaluate for other TSC manifestations and consider genetic testing for TSC1/TSC2 mutations 6

  5. If vitiligo suspected in adults: Consider thyroid function testing given 34% prevalence of autoimmune thyroid disease 3

Critical Pitfall to Avoid

Do not rely solely on clinical appearance - hypopigmented macules in infants can look identical to the naked eye. The British Association of Dermatologists guideline explicitly states that "in patients with an atypical presentation, diagnosis is more difficult and referral for expert assessment by a dermatologist is recommended" 3. Dermoscopy significantly improves diagnostic accuracy and should be used routinely when differentiating these conditions 1, 2.

The presence of multiple hypopigmented macules in an infant with other concerning features (seizures, cardiac findings) warrants urgent evaluation for tuberous sclerosis, as this has significant implications for morbidity and mortality through associated complications like cardiac rhabdomyomas and renal angiomyolipomas 5, 6.

Related Questions

What are the differential diagnoses for hypopigmented, dry patches on the abdominal skin?
What are the likely causes of itchy hypopigmented patches on the arms and legs, and how can they be distinguished and treated?
In a 4‑year‑old child with new hypopigmented periorbital patches and a depigmented chin patch noted over the past 4 months, can congenital pigmentary disorders such as Waardenburg syndrome or piebaldism still be the cause despite the lesions not being present at birth?
What are the possible diagnoses for a 4-year-old child presenting with bilateral symmetric hypopigmented periorbital patches, a depigmented chin (mental) patch, congenital alopecia, lesions that began 4 months ago, and aggressive behavior?
In a 4-year-old child with bilateral symmetric hypopigmented patches around the eyes and a depigmented area under the chin that began 4 months ago and previously improved with tacrolimus 0.03%, what is the most likely diagnosis and appropriate next steps in management?
What is the recommended hydrocortisone dosing regimen for a pregnant woman with an acute exacerbation of bronchitis?
How many weeks should infliximab (Remicade) be withheld after surgery?
Do hypomelanotic macules (ash-leaf spots) in tuberous sclerosis exhibit accentuated whiteness under Wood's light examination?
What are the combined toxicities of tigecycline and daptomycin and how should they be monitored?
What are the recommended scheduling and preparation guidelines for a pediatric videofluoroscopic barium swallow, including fasting requirements, barium sulfate suspension concentration, mixing methods, volume per trial, and post‑procedure care?
What are the recommended fasting times, allowed fluids, medication considerations, and post‑procedure diet for a pediatric patient undergoing a barium swallow?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.